vs
Side-by-side financial comparison of A2Z CUST2MATE SOLUTIONS CORP. (AZ) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.
A2Z CUST2MATE SOLUTIONS CORP. is the larger business by last-quarter revenue ($1.5M vs $1.2M, roughly 1.3× Lucid Diagnostics Inc.). A2Z CUST2MATE SOLUTIONS CORP. runs the higher net margin — -90.4% vs -858.5%, a 768.1% gap on every dollar of revenue. On growth, Lucid Diagnostics Inc. posted the faster year-over-year revenue change (3.3% vs -1.6%).
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
AZ vs LUCD — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $1.2M |
| Net Profit | $-1.4M | $-10.4M |
| Gross Margin | 34.0% | — |
| Operating Margin | -265.9% | -971.0% |
| Net Margin | -90.4% | -858.5% |
| Revenue YoY | -1.6% | 3.3% |
| Net Profit YoY | 60.4% | 16.0% |
| EPS (diluted) | — | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.5M | $1.2M | ||
| Q2 25 | $1.2M | $1.2M | ||
| Q1 25 | $2.0M | $828.0K | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | $1.6M | $1.2M | ||
| Q2 24 | $1.1M | $976.0K | ||
| Q1 24 | — | $1.0M | ||
| Q4 23 | — | $1.0M |
| Q3 25 | $-1.4M | $-10.4M | ||
| Q2 25 | $-12.6M | $-4.4M | ||
| Q1 25 | $-6.8M | $-26.9M | ||
| Q4 24 | — | $-11.5M | ||
| Q3 24 | $-3.5M | $-12.4M | ||
| Q2 24 | $-3.2M | $-11.0M | ||
| Q1 24 | — | $-10.6M | ||
| Q4 23 | — | $-10.8M |
| Q3 25 | 34.0% | — | ||
| Q2 25 | 23.3% | — | ||
| Q1 25 | 31.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 43.9% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | -265.9% | -971.0% | ||
| Q2 25 | -585.9% | -978.8% | ||
| Q1 25 | -381.4% | -1508.1% | ||
| Q4 24 | — | -1033.8% | ||
| Q3 24 | -167.0% | -997.8% | ||
| Q2 24 | -272.1% | -1146.7% | ||
| Q1 24 | — | -1078.1% | ||
| Q4 23 | — | -1101.3% |
| Q3 25 | -90.4% | -858.5% | ||
| Q2 25 | -1085.4% | -381.7% | ||
| Q1 25 | -342.1% | -3249.8% | ||
| Q4 24 | — | -964.2% | ||
| Q3 24 | -224.7% | -1055.5% | ||
| Q2 24 | -277.4% | -1127.6% | ||
| Q1 24 | — | -1060.1% | ||
| Q4 23 | — | -1041.3% |
| Q3 25 | — | $-0.10 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | $-0.19 | $-0.52 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | $-0.15 | $-0.25 | ||
| Q2 24 | $-0.05 | $-0.23 | ||
| Q1 24 | — | $-0.40 | ||
| Q4 23 | — | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.2M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $71.3M | $25.8M |
| Total Assets | $81.9M | $53.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $43.2M | $47.3M | ||
| Q2 25 | $28.5M | $31.1M | ||
| Q1 25 | $24.2M | $25.2M | ||
| Q4 24 | — | $22.4M | ||
| Q3 24 | $3.4M | $14.5M | ||
| Q2 24 | $653.0K | $24.9M | ||
| Q1 24 | — | $24.8M | ||
| Q4 23 | — | $18.9M |
| Q3 25 | $71.3M | $25.8M | ||
| Q2 25 | $31.5M | $7.9M | ||
| Q1 25 | $31.3M | $-5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | $-504.0K | $6.3M | ||
| Q2 24 | $-340.0K | $16.0M | ||
| Q1 24 | — | $11.9M | ||
| Q4 23 | — | $-2.3M |
| Q3 25 | $81.9M | $53.2M | ||
| Q2 25 | $46.1M | $38.7M | ||
| Q1 25 | $42.2M | $32.8M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | $10.2M | $22.6M | ||
| Q2 24 | $7.2M | $34.1M | ||
| Q1 24 | — | $32.0M | ||
| Q4 23 | — | $27.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.0M | $-10.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-4.0M | $-10.9M | ||
| Q2 25 | $-5.9M | $-10.5M | ||
| Q1 25 | $-3.8M | $-12.5M | ||
| Q4 24 | — | $-9.9M | ||
| Q3 24 | $-658.0K | $-10.2M | ||
| Q2 24 | $-3.7M | $-11.5M | ||
| Q1 24 | — | $-12.6M | ||
| Q4 23 | — | $-10.0M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
